Search results
Early June seeing uptick in summer colds, viruses, COVID-19 cases on Long Island, doctors say
Newsday· 1 day agoEarly June has seen a "burst of COVID" along with a variety pack of colds, viruses and other...
A Guide to Managing Covid This Summer
New York Times· 4 days agoHere’s what to know about symptoms, testing and treatment. KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers...
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoLast spring, he enrolled in a clinical trial of a new long COVID therapy at Stanford University, and he's about to start another at the University of...
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 1 day agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies ...
Setting sights on universal protection for flu
Medical Xpress· 7 days agoVanderven is determined to find a way to reduce the number of people becoming severely unwell and dying from the flu. ''My research has a two-fold focus,...
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
CNBC· 20 hours agoAlphabet's outgoing finance chief, Ruth Porat, spent the past year and a half trying to help her internet company navigate the generative artificial intelligence boom. Alphabet announced on ...
Cancer vaccine hailed as 'game-changer'
Newsweek· 7 days agoCancer patients in the U.K. are about to get personalized cancer vaccines as part of a new trial. Unlike vaccines for diseases like the flu or COVID-19,...
First Ever Human Case Of H5N2 Bird Flu Leads To Death In Mexico
IFLScience· 1 day agoA man in Mexico has died after contracting the first lab-confirmed human infection with H5N2 bird...
Once-Weekly Somapacitan Remains Safe, Effective Long-Term
Medscape· 8 hours agoGrowth improvements were similar between children taking somapacitan for 3 years and those who...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 8 hours agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
